Insulin-like growth factor-1, insulin-like growth factor binding protein-3, and cardiovascular disease risk factors in young black men and white men: The CARDIA male hormone study

American Journal of Epidemiology

Volumn 160, Issue 8, 2004, Pages 750-757

  Colangelo, Laura A ^a   Liu, Kiang ^a   Gapstur, Susan M ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Cardiovascular diseases; Insulin like growth factor binding protein 3; Insulin like growth factor I; Men; Risk factors

Indexed keywords

CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

CARDIOVASCULAR DISEASE;

ADULT; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CORRELATION ANALYSIS; EUROPEAN AMERICAN; HUMAN; HUMAN CELL; HYPERTENSION; INFORMATION PROCESSING; LIPID BLOOD LEVEL; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEGRO; RISK FACTOR; STATISTICAL ANALYSIS;

ADULT; AFRICAN AMERICANS; ALABAMA; CALIFORNIA; CARDIOVASCULAR DISEASES; CHICAGO; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; EXERCISE; FOLLOW-UP STUDIES; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; LIFE STYLE; MALE; MINNESOTA; MULTIVARIATE ANALYSIS; OBESITY; RISK ASSESSMENT; RISK FACTORS; SMOKING;

EID: 5444243622     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/kwh289     Document Type: Article

References (29)

1. LeRoith D, Clemmons D, Nissley P, et al. Insulin-like growth factors in health and disease. Ann Intern Med 1992;116:854-62.
2. Bayes-Genis A, Conover CA, Schwartz RS. The insulin-like growth factor axis: a review of atherosclerosis and restenosis. Circ Res 2000;86:125-30.
3. Ferns GA, Motani AS, Anggard EE. The insulin-like growth factors: their putative role in atherogenesis. Artery 1991;18:197-225.
4. Prewitt TE, Unterman TG, Glick R, et al. Insulin-like growth factor I and low-density-lipoprotein cholesterol in women during high- and low-fat feeding. Am J Clin Nutr 1992;55:381-4.
5. Probst-Hensch NM, Wang H, Goh VH, et al. Determinants of circulating insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations in a cohort of Singapore men and women. Cancer Epidemiol Biomarkers Prev 2003;12:739-46.
6. Andronico G, Mangano MT, Nardi E, et al. Insulin-like growth factor 1 and sodium-lithium countertransport in essential hypertension and in hypertensive left ventricular hypertrophy. J Hypertens 1993;11:1097-101.
7. Diez J, Ruilope LM, Rodicio JL. Insulin response to oral glucose in essential hypertensives with increased circulating levels of insulin growth factor I. J Hypertens Suppl 1991;9:S174-5.
8. Diez J, Laviades C. Insulin-like growth factor-1 and cardiac mass in essential hypertension: comparative effects of captopril, lisinopril and quinapril. J Hypertens Suppl 1994;12:S31-6.
9. Lemne C, Brismar K. Insulin-like growth factor binding protein-1 as a marker of the metabolic syndrome - a study in borderline hypertension. Blood Press 1998;7:89-95.
10. Landin-Wilhelmsen K, Wilhelmsen L, Lappas G, et al. Serum insulin-like growth factor I in a random population sample of men and women: relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin. Clin Endocrinol 1994;41:351-7.
11. Friedman GD, Cutter GR, Donahue RP, et al. CARDIA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol 1988;41:1105-16.
12. Warnick GR, Benderson J, Albers JJ. Enzymatic methods for quantification of lipoprotein lipids. Methods Enzymol 1986;129:101-23.
13. Warnick GR, Benderson J, Albers JJ. Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem 1982;28:1379-88.
14. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
15. Dyer AR, Cutter GR, Liu KQ, et al. Alcohol intake and blood pressure in young adults: The CARDIA Study. J Clin Epidemiol 1990;43:1-13.
16. Jacobs DR Jr, Hahn LP, Haskell WL, et al. Validity and reliability of short physical activity history: CARDIA and the Minnesota Heart Health Program. J Cardiopulm Rehabil 1989;9:448-59.
17. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986;73:13-22.
18. Janssen JA, Stolk RP, Pols HA, et al. Serum total IGF-I, free IGF-I, and IGFB-1 levels in an elderly population: relation to cardiovascular risk factors and disease. Arterioscler Thromb Vasc Biol 1998;18:277-82.
19. Jiang X, Srinivasan SR, Dalferes ER Jr, et al. Plasma insulin-like growth factor 1 distribution and its relation to blood pressure in adolescents: The Bogalusa Heart Study. Am J Hypertens 1997;10:714-19.
20. Laviades C, Major G, Diez J. Elevated circulating levels of insulin-like growth factor I in essential hypertensive patients with left ventricular hypertrophy. Arch Mal Coeur Vaiss 1991;84:1039-41.
21. Wåhlander H, Isgaard J, Jennische E, et al. Left ventricular insulin-like growth factor I increases in early renal hypertension. Hypertension 1992;19:25-32.
22. Ceda GP, Dall'Aglio E, Magnacavallo A, et al. The insulin-like growth factor axis and plasma lipid levels in the elderly. J Clin Endocrinol Metab 1998;83:499-502.
23. Schuler-Lüttmann S, Monnig G, Enbergs A, et al. Insulin-like growth factor-binding protein-3 is associated with the presence and extent of coronary arteriosclerosis. Arterioscler Thromb Vasc Biol 2000;20:E10-15.
24. Juul A, Scheike T, Davidsen M, et al. Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study. Circulation 2002;106:939-44.
25. Vaessen N, Heutink P, Janssen JA, et al. A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction. Diabetes 2001;50:637-42.
26. Goodman-Gruen D, Barrett-Connor E, Rosen C. IGF-1 and ischemic heart disease in older people. J Am Geriatr Soc 2000;48:860-1.
27. Ruotolo G, Bavenholm P, Brismar K, et al. Serum insulin-like growth factor-I level is independently associated with coronary artery disease progression in young male survivors of myocardial infarction: beneficial effects of bezafibrate treatment. J Am Coll Cardiol 2000;35:647-54.
28. Botker HE, Skjaerbaek C, Eriksen UH, et al. Insulin-like growth factor-I, insulin, and angina pectoris secondary to coronary atherosclerosis, vasospasm, and syndrome X. Am J Cardiol 1997;79:961-3.
29. Janssen JA, Lamberts SW. The role of IGF-I in the development of cardiovascular disease in type 2 diabetes mellitus: is prevention possible? Eur J Endocrinol 2002;146:467-77.